AllNexImmune NexImmune Strengthens Scientific Leadership by Appointing Jerome Zeldis as EVP R&D and Jeffrey Weber as Chief Scientific Advisor Zeldis formerly served as Celgene CMO and CEO of Celgene Global HealthWeber is a renowned…skylarbennethumJanuary 5, 2021
AllCereno Scientific Cereno Scientific terminates agreement with liquidity provider TUE, DEC 22, 2020 16:30 CET Cereno Scientific announced today that the agreement with Mangold…skylarbennethumDecember 22, 2020
AllNexImmune Preliminary Results from NexImmune’s Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition Initial data demonstrate early signs of safety, tolerability and robust immune responses in acute myeloid…skylarbennethumDecember 7, 2020
3DBio TherapeuticsAll 3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients NEW YORK, Nov. 19, 2019 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for…skylarbennethumNovember 19, 2020
AllNexImmune NexImmune to Highlight Preliminary Results from Phase 1/2 Trial of NEXI-001 via Oral Presentation at 62nd ASH Annual Meeting GAITHERSBURG, Md., Nov. 04, 2020 (GLOBE NEWSWIRE) -- NexImmune, a clinical-stage biotechnology company developing unique…skylarbennethumNovember 4, 2020
AllNexImmune NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia City of Hope will combine its world-leading expertise with NexImmune technology to explore tumor escape…skylarbennethumOctober 27, 2020